[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350060-105":59,"doc-detail-350060-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","study-of-high-levels-of-wilms-tumor-1-wt1-expression-in-ovarian-cancers-research-findings","Study of High Levels of Wilms’ Tumor 1 (WT1) Expression in Ovarian Cancers - Research Findings","","Ovarian cancer causes high mortality in women and remains difficult to diagnose and treat due to heterogeneity, limited screening, and frequent late presentation. Accurate histopathological classification with immunohistochemical markers is therefore essential. This prospective observational study evaluated 300 confirmed epithelial ovarian tumors, assessing Wilms’ tumor 1 (WT1) nuclear immunoreactivity and its relationship with histological subtype and FIGO stage. WT1 positivity predominated in serous carcinomas and correlated with advanced FIGO stages.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/study-of-high-levels-of-wilms-tumor-1-wt1-expression-in-ovarian-cancers-research-findings/350060/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/study-of-high-levels-of-wilms-tumor-1-wt1-expression-in-ovarian-cancers-research-findings/350060.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study examining about ovarian cancer?","Question",{"text":112,"@type":113},"The study evaluates high levels of Wilms’ Tumor 1 (WT1) expression in ovarian cancers and how WT1 immunohistochemistry relates to tumor features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tumors selected and how was WT1 tested?",{"text":117,"@type":113},"The study included 300 histopathologically confirmed epithelial ovarian tumors and excluded several other categories. Tumors were stained with hematoxylin and eosin and assessed for WT1 via immunohistochemistry, categorizing cases as WT1-positive or WT1-negative based on nuclear immunoreactivity.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about WT1 positivity?",{"text":121,"@type":113},"WT1 positivity was mainly observed in serous carcinomas, while mucinous and seromucinous tumors were WT1-negative. WT1 positivity was significantly associated with advanced FIGO stages in serous carcinomas.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350060,1790203022,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review began 02/23/2026  \nReview ended 02/27/2026  \nPublished 03/01/2026  \n© Copyright 2026  \nFatima et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.104521  \nOpen Access Original Article  \nStudy of High Levels of Wilms’ Tumor 1 (WT1) Expression in Ovarian Cancers  \nArshia Fatima 1 , Sunita Pawar 1 , Dnyaneshwar Potpalle 2, Hari Chandana 3, Mummareddi Dinesh Eshwar 4  \n1. Pathology and Laboratory Medicine, Mahavir Institute of Medical Sciences, Vikarabad, IND 2. Pediatrics, Mahavir Institute of Medical Sciences, Vikarabad, IND 3. Pathology and Laboratory Medicine, Dr. Patnam Mahendar Reddy Institute of Medical Sciences, Chevella, IND 4. General Medicine, Mahavir Institute of Medical Sciences, Vikarabad, IND  \nCorresponding author: Dnyaneshwar Potpalle, [gyan.patil@gmail.com](gyan.patil@gmail.com)  \nAbstract  \nBackground  \nOvarian cancer is a major cause of cancer-related mortality among women and remains a significant diagnostic and therapeutic challenge due to its heterogeneous nature, absence of effective screening strategies, and frequent presentation at advanced stages. Surface epithelial ovarian tumors constitute the largest group of ovarian neoplasms and account for the majority of malignant cases. These tumors encompass multiple histological subtypes with distinct morphological features, biological behavior, and prognostic implications. Accurate histopathological classification supported by immunohistochemical markers is, therefore, essential for diagnosis and prognostication. Wilms’ tumor 1 (WT1) is a zinc finger transcription factor involved in cellular proliferation, differentiation, apoptosis, and regulation of the cell cycle. Although initially described as a tumor suppressor gene, WT1 has been shown to demonstrate oncogenic behavior in several malignancies, particularly ovarian cancer, and is strongly associated with serous ovarian carcinoma.  \nMethods  \nThis prospective observational study was conducted over a two-year period and included 300 histopathologically confirmed epithelial ovarian tumors. Borderline and malignant epithelial ovarian tumors were included, while benign ovarian tumors, non-epithelial ovarian tumors, inflammatory lesions, and metastatic tumors involving the ovary were excluded. Surgically excised specimens and biopsy samples obtained during routine clinical care were fixed in formalin and processed using standard histopathological techniques. Sections were stained with hematoxylin and eosin for microscopic evaluation and tumor classification. Immunohistochemical staining for WT1 was performed on representative tissue sections, and tumors were categorized as WT1-positive or WT1-negative based on nuclear immunoreactivity. WT1 positivity was analyzed for its association with histological subtype and International Federation of Gynecology and Obstetrics (FIGO) stage.  \nResults  \nMalignant tumors constituted the majority of cases, while borderline tumors accounted for a smaller proportion. Serous tumors were the most common histological subtype, followed by mucinous tumors, seromucinous tumors, and poorly differentiated adenocarcinomas. WT1 positivity demonstrated a distinct distribution across tumor subtypes. Nuclear WT1 positivity was predominantly observed in serous carcinomas, while mucinous and seromucinous tumors were WT1-negative. Borderline serous tumors showed WT1 positivity less frequently. WT1 positivity was significantly associated with advanced FIGO stages in serous carcinomas.  \nConclusion  \nWT1 is a sensitive and reliable immunohistochemical marker for serous ovarian carcinoma and is useful in distinguishing serous tumors from other epithelial ovarian neoplasms. The association between WT1 positivity and advanced tumor stage suggests a potential prognosti","cbCaiveOHvFHcGYA","https://ap.wps.com/l/cbCaiveOHvFHcGYA","pdf",180002,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# How to cite this article","[{\"question\":\"What is the study examining about ovarian cancer?\",\"answer\":\"The study evaluates high levels of Wilms’ Tumor 1 (WT1) expression in ovarian cancers and how WT1 immunohistochemistry relates to tumor features.\"},{\"question\":\"How were tumors selected and how was WT1 tested?\",\"answer\":\"The study included 300 histopathologically confirmed epithelial ovarian tumors and excluded several other categories. Tumors were stained with hematoxylin and eosin and assessed for WT1 via immunohistochemistry, categorizing cases as WT1-positive or WT1-negative based on nuclear immunoreactivity.\"},{\"question\":\"What did the results show about WT1 positivity?\",\"answer\":\"WT1 positivity was mainly observed in serous carcinomas, while mucinous and seromucinous tumors were WT1-negative. WT1 positivity was significantly associated with advanced FIGO stages in serous carcinomas.\"}]","Study of High Levels of Wilms’ Tumor 1 (WT1) Expression in Ovarian Cancers - Research Findings | PDF",1790086964,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a40c11fb2bfc7c8226f3d7db626154a7.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18b251100c706d7e0e13a083a3a1ef23.webp",982,1389,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2de1c006211c664d16047f576ee0539e.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/779dfad75856a52a3651818f033123aa.webp",980,1386]